Literature DB >> 6307210

Development of accelerated atherosclerosis. Concepts derived from cell biology and animal model studies.

R W Mahley.   

Abstract

Atherosclerosis can be defined as a disease process that occurs when the influx and deposition of cholesterol into the arterial wall exceed the egress of cholesterol from the arterial wall. This process is characterized by early deposition of cholesterol in and around arterial wall cells. The cholesterol is derived from certain types of plasma lipoproteins. While these lipoproteins deliver cholesterol to the arterial wall cells, other types of plasma lipoproteins may be capable of removing cholesterol from the cells and transporting the cholesterol to the liver for excretion from the body. As the involvement of various lipoproteins in cholesterol influx and egress is better understood, the mechanisms whereby accelerated atherosclerosis occurs are more clearly defined. This review considers recent findings related to identification of lipoproteins capable of delivering cholesterol to cells of the arterial wall and those capable of removing cholesterol from these cells for transport to the liver.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307210

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  9 in total

1.  Severe xanthomatosis associated with familial apolipoprotein E deficiency.

Authors:  G Feussner
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

2.  Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis.

Authors:  G Feussner; J Bommer; R Ziegler
Journal:  Klin Wochenschr       Date:  1990-01-19

3.  Lipoprotein binding to cultured human hepatoma cells.

Authors:  F Krempler; G M Kostner; W Friedl; B Paulweber; H Bauer; F Sandhofer
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

4.  Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.

Authors:  S Bellosta; R W Mahley; D A Sanan; J Murata; D L Newland; J M Taylor; R E Pitas
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

5.  Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors.

Authors:  C Koo; M E Wernette-Hammond; Z Garcia; M J Malloy; R Uauy; C East; D W Bilheimer; R W Mahley; T L Innerarity
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

6.  Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  J Lipid Res       Date:  2008-12-22       Impact factor: 5.922

7.  Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages.

Authors:  T P Bersot; T L Innerarity; R E Pitas; S C Rall; K H Weisgraber; R W Mahley
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

8.  Characteristics of the plaque under a coronary thrombus.

Authors:  R E Tracy; K Devaney; G Kissling
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

9.  Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits.

Authors:  A Shaish; A Daugherty; F O'Sullivan; G Schonfeld; J W Heinecke
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.